Advancing Ultrasound: AI, Diagnostics, Therapies
Received: 02-May-2025 / Manuscript No. jcd-25-175133 / Editor assigned: 05-May-2025 / PreQC No. jcd-25-175133 (PQ) / Reviewed: 19-May-2025 / QC No. jcd-25-175133 / Revised: 23-May-2025 / Manuscript No. jcd-25-175133 (R) / Accepted Date: 30-May-2025 / Published Date: 30-May-2025
Abstract
Medical ultrasound is evolving rapidly, driven by innovations across diagnostic and therapeutic applications. Deep learning is transforming medical ultrasound, enhancing image acquisition, reconstruction, and intelligent diagnosis, making it smarter and more precise. Artificial Intelligence is also improving liver fibrosis assessment and fetal anomaly detection. Specialized techniques like contrast-enhanced ultrasound aid in liver metastasis diagnosis, while intravascular ultrasound is crucial for coronary artery disease. Photoacoustic imaging combines light and sound for high-resolution cancer detection. Point-of-Care Ultrasound offers rapid bed side diagnostics, and therapeutic ultrasound enhances targeted drug delivery, including microbubble-mediated approaches. These advancements underscore ultrasound’s versatile and non-invasive role in modern medicine.
Keywords
Medical Ultrasound; Deep Learning; Artificial Intelligence; Drug Delivery; Neuroimaging; Contrast-Enhanced Ultrasound (CEUS); Photoacoustic Imaging; Point-of-Care Ultrasound (POCUS); Intravascular Ultrasound (IVUS); Fetal Ultrasound
Introduction
The field of medical ultrasound is experiencing a profound transformation, marked by significant advancements in both diagnostic and therapeutic applications. These innovations are reshaping clinical practices, enhancing diagnostic precision, and offering new avenues for patient care. Across a diverse range of specialties, from cardiology to prenatal imaging and oncology, ultrasound technology continues to evolve, often integrating cutting-edge computational approaches like Artificial Intelligence (AI) and deep learning to push the boundaries of what is possible. Deep learning, for example, is fundamentally transforming medical ultrasound, moving beyond traditional tasks to unlock novel applications. It encompasses advancements in image acquisition, reconstruction, enhancement, and intelligent diagnosis, making ultrasound inherently smarter, faster, and more precise, which significantly pushes the boundaries of what's possible in clinical imaging[1].
Building on this, the integration of Artificial Intelligence with ultrasound elastography has been extensively explored for assessing liver fibrosis. This approach demonstrates substantial potential to improve diagnostic accuracy and streamline the evaluation process, providing a less invasive and more reliable method for disease staging compared to traditional biopsies[2].
Meanwhile, ultrasound neuroimaging is emerging as a critical tool, offering a concise overview of its utility in diagnosing and monitoring various brain pathologies. Its non-invasive nature and portability make it an invaluable asset for bedside assessment and early detection of neurological conditions, particularly in challenging clinical scenarios[3].
Another vital development is the role of contrast-enhanced ultrasound (CEUS) in diagnosing liver metastases. CEUS is recognized as a powerful imaging modality capable of characterizing focal liver lesions and significantly improving the detection of metastatic disease, offering real-time visualization and dynamic assessment without any radiation exposure[4].
In a related domain, photoacoustic imaging offers an insightful look into its current technological status and diverse applications, especially in cancer detection and characterization. This technique combines light absorption with ultrasound detection to provide high-resolution, high-contrast images, effectively bridging the gap between purely optical and purely ultrasonic methods[5].
The practical application of ultrasound extends to point-of-care ultrasound (POCUS) in internal medicine. This modality is revolutionizing patient care by utilizing portable ultrasound devices that enable rapid, real-time diagnostic imaging at the bedside, leading to quicker decisions and improved patient outcomes across various clinical settings[6].
Beyond diagnostics, therapeutic ultrasound is advancing significantly, particularly for improving drug delivery across biological barriers. It leverages mechanisms like sonoporation and cavitation, demonstrating how ultrasound can non-invasively enhance drug penetration to target tissues, promising more effective treatments for various diseases, including cancer and neurological disorders[7].
In cardiovascular diagnostics, intravascular ultrasound (IVUS) maintains a critical role in diagnosing and managing coronary artery disease. IVUS provides high-resolution, cross-sectional images of coronary arteries, offering detailed insights into plaque morphology, lesion severity, and stent optimization, all of which are crucial for guiding interventional procedures[8].
Further demonstrating AI's impact, current and future prospects of artificial intelligence in fetal ultrasound are being actively explored. AI algorithms are significantly improving the accuracy and efficiency of fetal anomaly detection, growth assessment, and risk stratification, potentially transforming prenatal care by assisting clinicians with complex image analysis[9].
Finally, a comprehensive review highlights ultrasound-microbubble-mediated drug delivery, detailing how microbubbles, activated by ultrasound, can safely and effectively enhance the localized delivery of therapeutic agents. This innovative technique covers underlying principles, current applications, and future potential across various medical fields, including oncology and gene therapy[10].
Description
The landscape of medical ultrasound is undergoing rapid evolution, driven by significant technological and methodological advancements across a broad spectrum of clinical applications. A key driver in this profound transformation is the pervasive integration of Artificial Intelligence (AI) and deep learning, which are consistently pushing the boundaries of what is diagnostically and therapeutically achievable. Deep learning, for example, is fundamentally revolutionizing medical ultrasound by comprehensively enhancing image acquisition, reconstruction, and intelligent diagnosis, moving adeptly beyond conventional tasks to unlock truly novel applications, thus making ultrasound inherently smarter, faster, and more precise in diverse clinical imaging scenarios [1]. Similarly, the tangible potential of AI is clearly demonstrated in its innovative integration with ultrasound elastography for the accurate assessment of liver fibrosis. This advanced combination not only improves diagnostic accuracy but also streamlines the entire evaluation process, offering a significantly less invasive and more reliable method for disease staging when compared to traditional, often invasive, biopsies [2]. Furthermore, AI algorithms are proving incredibly valuable in the sensitive domain of fetal ultrasound, where they substantially improve the accuracy and efficiency of critical fetal anomaly detection, growth assessment, and risk stratification, poised to fundamentally transform prenatal care by assisting clinicians with complex image analysis and interpretation [9].
Expanding beyond general applications, specialized diagnostic ultrasound techniques are vastly broadening the utility and reach of this versatile imaging modality. Ultrasound neuroimaging, for instance, provides a concise yet powerfully effective overview of its expanding application in diagnosing and continuously monitoring various brain pathologies. Its inherent non-invasive nature and remarkable portability make it an absolutely essential tool for rapid bedside assessment and crucially, for the early detection of neurological conditions, particularly in challenging and time-sensitive clinical scenarios [3]. In the critical realm of oncology, contrast-enhanced ultrasound (CEUS) stands out as an indispensable update, specifically in its vital role in diagnosing liver metastases. CEUS is recognized as an exceptionally powerful imaging modality capable of precisely characterizing focal liver lesions and significantly improving the overall detection rate of metastatic disease, providing real-time visualization and dynamic assessment without any undesirable radiation exposure [4].
Continuing the exploration of advanced diagnostics, intravascular ultrasound (IVUS) maintains a profoundly critical role in the accurate diagnosis and comprehensive management of coronary artery disease. IVUS delivers exceptionally high-resolution, cross-sectional images of coronary arteries, offering highly detailed insights into intricate plaque morphology, the severity of lesions, and crucial stent optimization, all of which are absolutely essential for precisely guiding complex interventional procedures [8]. Bridging the gap between purely optical and purely ultrasonic methods, photoacoustic imaging offers an insightful and comprehensive look into its current technological status and diverse applications, particularly in the early detection and detailed characterization of cancer. This innovative technique ingeniously leverages light absorption in conjunction with ultrasound detection to generate high-resolution, high-contrast images, significantly expanding the diagnostic capabilities for challenging conditions [5].
A particularly transformative development in clinical practice is the rise of point-of-care ultrasound (POCUS), which surveys its current state and future prospects extensively in internal medicine. POCUS distinctly highlights how highly portable ultrasound devices are unequivocally revolutionizing patient care by enabling rapid, real-time diagnostic imaging directly at the patient's bedside. This crucial capability invariably leads to quicker, more informed clinical decisions and substantially improved patient outcomes across a remarkably wide array of diverse clinical settings [6].
Finally, the therapeutic applications of ultrasound are witnessing substantial and impactful advancements, especially concerning enhanced drug delivery. Therapeutic ultrasound, exploring its sophisticated mechanisms for improved drug delivery across formidable biological barriers, meticulously details processes like sonoporation and cavitation. These mechanisms demonstrably show how ultrasound can non-invasively and precisely enhance drug penetration to specifically target tissues, promising more effective and localized treatments for a myriad of various diseases, including challenging cancers and debilitating neurological disorders [7]. This pioneering approach is further exemplified by ultrasound-microbubble-mediated drug delivery, presented in a comprehensive review that meticulously details how microbubbles, activated by ultrasound, can safely and effectively enhance the localized delivery of therapeutic agents. It covers the underlying physical principles, current successful applications, and the immense future potential of this innovative technique in diverse medical fields such, as oncology and gene therapy [10].
Conclusion
Current advancements in ultrasound technology are significantly broadening its diagnostic and therapeutic capabilities across various medical fields. Artificial Intelligence (AI) and deep learning are at the forefront of this evolution, making ultrasound more precise and efficient. For instance, AI transforms medical ultrasound by improving image acquisition, reconstruction, enhancement, and intelligent diagnosis, moving beyond traditional tasks to unlock novel applications. AI also plays a crucial role in improving diagnostic accuracy for liver fibrosis assessment when integrated with ultrasound elastography, offering a less invasive alternative to biopsies. Similarly, AI algorithms are enhancing fetal ultrasound by improving anomaly detection, growth assessment, and risk stratification, thereby transforming prenatal care. Beyond AI, specialized ultrasound modalities offer unique diagnostic insights. Ultrasound neuroimaging provides a non-invasive and portable tool for diagnosing and monitoring brain pathologies, particularly useful in acute clinical settings. Contrast-Enhanced Ultrasound (CEUS) is a powerful tool for characterizing focal liver lesions and detecting metastases, providing real-time visualization without radiation. Photoacoustic imaging combines light absorption with ultrasound detection to deliver high-resolution, high-contrast images, bridging the gap between optical and ultrasonic methods for applications like cancer detection. Therapeutic applications are also expanding. Point-of-Care Ultrasound (POCUS) is revolutionizing internal medicine by enabling rapid, real-time diagnostic imaging at the patient's bedside, leading to quicker decisions and improved patient outcomes in various clinical settings. Therapeutic ultrasound leverages mechanisms like sonoporation and cavitation to enhance drug delivery across biological barriers, promising more effective treatments for conditions such as cancer and neurological disorders. This is further refined by ultrasound-microbubble-mediated drug delivery, which offers a safe and localized method for targeted therapeutic agent delivery in oncology and gene therapy. Intravascular Ultrasound (IVUS) remains vital in cardiology, providing high-resolution images of coronary arteries to guide interventional procedures by detailing plaque morphology and optimizing stent placement. The collective progress highlights ultrasound as an indispensable, versatile, and continuously innovating tool in healthcare.
References
- Mengmeng L, Yu-Chi L, Zaiyi L (2022) .Med Image Anal 82:102580.
, ,
- Zhenchao W, Rui Y, Jianhua L (2023) .Eur Radiol 33:7425-7436.
, ,
- Xin L, Xiangrui R, Wenting L (2022) .J Ultrasound 25:205-212.
, ,
- Jianan L, Yumei L, Bingchen Y (2021) .Front Oncol 11:704149.
, ,
- Jin-Woo K, Young-Min K, Yoonseong C (2020) .Sensors (Basel) 20:5666.
, ,
- Yuancheng L, Guodong Z, Xinjia C (2023) .Front Med (Lausanne) 10:1162446.
, ,
- Wei Z, Yuxin G, Zhengyang Z (2022) .Theranostics 12:3013-3030.
, ,
- Li-Zhen W, Wen-Li W, Yan-Li L (2021) .Front Cardiovasc Med 8:708056.
, ,
- Hao W, Jianhua Y, Weining F (2023) .Front Med (Lausanne) 10:1195655.
, ,
- Qian L, Hongfei S, Zilu L (2020) .J Med Ultrasound 28:1-13.
, ,
Citation: Matsuda H (2025) Advancing Ultrasound: AI, Diagnostics, Therapies. jcd 09: 297.
Copyright: 漏 2025 Hiroshi Matsuda This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 344
- [From(publication date): 0-0 - Apr 06, 2026]
- Breakdown by view type
- HTML page views: 271
- PDF downloads: 73
